- Home
- ATNM vs ASYS Comparison
ATNM vs ASYS Comparison
Compare ATNM & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- ASYS
- Stock Information
- Founded
- ATNM 2000
- ASYS 1981
- Country
- ATNM United States
- ASYS United States
- Employees
- ATNM N/A
- ASYS N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- ASYS Industrial Machinery/Components
- Sector
- ATNM Health Care
- ASYS Technology
- Exchange
- ATNM Nasdaq
- ASYS Nasdaq
- Market Cap
- ATNM 51.5M
- ASYS 49.8M
- IPO Year
- ATNM N/A
- ASYS N/A
- Fundamental
- Price
- ATNM $1.54
- ASYS $4.01
- Analyst Decision
- ATNM Strong Buy
- ASYS
- Analyst Count
- ATNM 3
- ASYS 0
- Target Price
- ATNM $4.67
- ASYS N/A
- AVG Volume (30 Days)
- ATNM 229.8K
- ASYS 81.5K
- Earning Date
- ATNM 05-09-2025
- ASYS 05-12-2025
- Dividend Yield
- ATNM N/A
- ASYS N/A
- EPS Growth
- ATNM N/A
- ASYS N/A
- EPS
- ATNM N/A
- ASYS N/A
- Revenue
- ATNM N/A
- ASYS $90,826,000.00
- Revenue This Year
- ATNM N/A
- ASYS N/A
- Revenue Next Year
- ATNM N/A
- ASYS $28.60
- P/E Ratio
- ATNM N/A
- ASYS N/A
- Revenue Growth
- ATNM N/A
- ASYS N/A
- 52 Week Low
- ATNM $1.03
- ASYS $3.20
- 52 Week High
- ATNM $8.64
- ASYS $6.96
- Technical
- Relative Strength Index (RSI)
- ATNM 49.81
- ASYS 54.53
- Support Level
- ATNM $1.56
- ASYS $3.62
- Resistance Level
- ATNM $1.69
- ASYS $4.24
- Average True Range (ATR)
- ATNM 0.11
- ASYS 0.24
- MACD
- ATNM -0.01
- ASYS 0.08
- Stochastic Oscillator
- ATNM 32.18
- ASYS 75.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.